Therapy of acute myelogeneous leukemia

Cancer. 1978 Aug;42(2 Suppl):874-82. doi: 10.1002/1097-0142(197808)42:2+<874::aid-cncr2820420709>3.0.co;2-o.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Cytarabine / therapeutic use
  • Doxorubicin / therapeutic use
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Fibrinogen / analysis
  • Humans
  • L-Lactate Dehydrogenase / blood
  • Leukemia, Myeloid, Acute / analysis
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Middle Aged
  • Prednisone / therapeutic use
  • Prognosis
  • Regression Analysis
  • Remission, Spontaneous
  • Time Factors
  • Vincristine / therapeutic use

Substances

  • Antineoplastic Agents
  • Cytarabine
  • Vincristine
  • Doxorubicin
  • Fibrinogen
  • L-Lactate Dehydrogenase
  • Prednisone